文献速递白血病

成人费城染色体阴性急性淋巴细胞白血病治疗的当前挑战与机遇

Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
PubMed 文献 · Br J Haematol · 2017-10-26

本综述汇总费城染色体阴性急性淋巴细胞白血病在生物学与遗传学、风险分层、诱导与缓解后策略及靶向治疗方面的新进展,并讨论年轻成人、老年/不适合及复发/难治患者的处理。

要点

  • 新的遗传亚型与异常可细化风险分层并揭示可操作的治疗靶点。
  • 年轻成人采用更强化的儿童及儿童启发方案似乎对该人群生存有积极影响。
  • 不同时间点的微小残留病可帮助基于个体反应制定风险适配干预。

核心结论

  • 本综述旨在整合大量新出现的数据,重新审视风险分层、诱导和缓解后策略的选择,并讨论和更新特定费城染色体阴性急性淋巴细胞白血病人群的处理方法。

研究设计与样本

  • 综述类:本文为叙述性综述,旨在整合费城染色体阴性急性淋巴细胞白血病领域的新出现数据并回顾相关概念。

主要发现

  • 新的遗传亚型和异常可细化风险分层并揭示新的可操作治疗靶点。
  • 纳入更强化的儿童及儿童启发方案似乎对年轻成人费城染色体阴性急性淋巴细胞白血病患者的生存有积极影响。
  • 不同时间点的微小残留病可帮助基于个体反应为患者制定风险适配干预。
  • 单克隆抗体、免疫治疗和小分子等新型靶向方法正在通过临床开发并进入临床。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Significant advances have been made in recent years in the field of Philadelphia-negative acute lymphoblastic leukaemia (ALL). New insights into the biology and genetics of ALL as well as novel clinical observations and new drugs are changing the way we diagnose, risk-stratify and treat adult patients with ALL. New genetic subtypes and alterations refine risk stratification and uncover new actionable therapeutic targets. The incorporation of more intensive, paediatric and paediatric-inspired approaches for young adults seem to have a positive impact on survival in this population. Minimal residual disease at different time points can assist in tailoring risk-adapted interventions for patients based on individual response. Finally, novel targeted approaches with monoclonal antibodies, immunotherapies and small molecules are moving through clinical development and entering the clinic. The aim of this review is to consolidate the abundance of emerging data and to review and revisit the concepts of risk-stratification, choice of induction and post-remission strategies as well as to discuss and update the approach to specific populations with ALL, such as young adult, elderly/unfit and relapsed/refractory patients with ALL.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wolach O, Amitai I, DeAngelo DJ, et al. Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia. Br J Haematol. 2017. PMID: 29076138. doi:10.1111/bjh.14916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。